Dalian Bio-Chem Co Ltd (603360) - Net Assets
Based on the latest financial reports, Dalian Bio-Chem Co Ltd (603360) has net assets worth CN¥2.05 Billion CNY (≈ $300.49 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥3.99 Billion ≈ $583.78 Million USD) and total liabilities (CN¥1.94 Billion ≈ $283.29 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check tangible net worth ratio of Dalian Bio-Chem Co Ltd to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥2.05 Billion |
| % of Total Assets | 51.47% |
| Annual Growth Rate | 18.77% |
| 5-Year Change | 94.22% |
| 10-Year Change | 345.03% |
| Growth Volatility | 17.05 |
Dalian Bio-Chem Co Ltd - Net Assets Trend (2011–2025)
This chart illustrates how Dalian Bio-Chem Co Ltd's net assets have evolved over time, based on quarterly financial data. See Dalian Bio-Chem Co Ltd (603360) liquidity interval to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Dalian Bio-Chem Co Ltd (2011–2025)
The table below shows the annual net assets of Dalian Bio-Chem Co Ltd from 2011 to 2025. For live valuation and market cap data, see 603360 market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥2.04 Billion ≈ $298.32 Million |
-13.29% |
| 2024-12-31 | CN¥2.35 Billion ≈ $344.05 Million |
+43.65% |
| 2023-12-31 | CN¥1.64 Billion ≈ $239.50 Million |
+12.01% |
| 2022-12-31 | CN¥1.46 Billion ≈ $213.83 Million |
+39.21% |
| 2021-12-31 | CN¥1.05 Billion ≈ $153.60 Million |
+6.21% |
| 2020-12-31 | CN¥988.28 Million ≈ $144.62 Million |
-4.37% |
| 2019-12-31 | CN¥1.03 Billion ≈ $151.23 Million |
+29.50% |
| 2018-12-31 | CN¥798.03 Million ≈ $116.78 Million |
+16.26% |
| 2017-12-31 | CN¥686.42 Million ≈ $100.45 Million |
+49.84% |
| 2016-12-31 | CN¥458.09 Million ≈ $67.03 Million |
+27.19% |
| 2015-12-31 | CN¥360.17 Million ≈ $52.70 Million |
+18.81% |
| 2014-12-31 | CN¥303.16 Million ≈ $44.36 Million |
+9.39% |
| 2013-12-31 | CN¥277.14 Million ≈ $40.55 Million |
+21.44% |
| 2012-12-31 | CN¥228.22 Million ≈ $33.40 Million |
+24.43% |
| 2011-12-31 | CN¥183.41 Million ≈ $26.84 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Dalian Bio-Chem Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2429.6% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥738.27 Million | 53.19% |
| Other Components | CN¥649.70 Million | 46.81% |
| Total Equity | CN¥1.39 Billion | 100.00% |
Dalian Bio-Chem Co Ltd Competitors by Market Cap
The table below lists competitors of Dalian Bio-Chem Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Husqvarna AB (publ)
ST:HUSQ-B
|
$1.94 Billion |
|
Zen Technologies Limited
NSE:ZENTEC
|
$1.94 Billion |
|
Forvia SE
PA:FRVIA
|
$1.94 Billion |
|
Baoding Lucky Innovative Materials Co Ltd
SHE:300446
|
$1.94 Billion |
|
Foran Energy Group Co Ltd
SHE:002911
|
$1.94 Billion |
|
Mednax Inc
NYSE:MD
|
$1.94 Billion |
|
Central Garden & Pet Company A
NASDAQ:CENTA
|
$1.94 Billion |
|
Shenzhen Aisidi Co Ltd
SHE:002416
|
$1.94 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Dalian Bio-Chem Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,788,474,436 to 1,387,975,399, a change of -400,499,037 (-22.4%).
- Net income of 209,774,694 contributed positively to equity growth.
- Dividend payments of 331,546,717 reduced retained earnings.
- Other factors decreased equity by 278,727,013.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥209.77 Million | +15.11% |
| Dividends Paid | CN¥331.55 Million | -23.89% |
| Other Changes | CN¥-278.73 Million | -20.08% |
| Total Change | CN¥- | -22.39% |
Book Value vs Market Value Analysis
This analysis compares Dalian Bio-Chem Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 9.55x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 25.58x to 9.55x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-12-31 | CN¥0.73 | CN¥18.77 | x |
| 2012-12-31 | CN¥0.84 | CN¥18.77 | x |
| 2013-12-31 | CN¥0.72 | CN¥18.77 | x |
| 2014-12-31 | CN¥0.56 | CN¥18.77 | x |
| 2015-12-31 | CN¥0.67 | CN¥18.77 | x |
| 2016-12-31 | CN¥0.85 | CN¥18.77 | x |
| 2017-12-31 | CN¥1.00 | CN¥18.77 | x |
| 2018-12-31 | CN¥1.12 | CN¥18.77 | x |
| 2019-12-31 | CN¥1.44 | CN¥18.77 | x |
| 2020-12-31 | CN¥1.38 | CN¥18.77 | x |
| 2021-12-31 | CN¥1.51 | CN¥18.77 | x |
| 2022-12-31 | CN¥2.11 | CN¥18.77 | x |
| 2023-12-31 | CN¥2.35 | CN¥18.77 | x |
| 2024-12-31 | CN¥2.52 | CN¥18.77 | x |
| 2025-12-31 | CN¥1.97 | CN¥18.77 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Dalian Bio-Chem Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 15.11%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 12.17%
- • Asset Turnover: 0.44x
- • Equity Multiplier: 2.81x
- Recent ROE (15.11%) is below the historical average (20.62%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 22.85% | 20.09% | 0.45x | 2.50x | CN¥23.57 Million |
| 2012 | 19.63% | 17.47% | 0.52x | 2.16x | CN¥21.99 Million |
| 2013 | 17.65% | 16.79% | 0.53x | 1.97x | CN¥21.21 Million |
| 2014 | 21.12% | 18.47% | 0.61x | 1.86x | CN¥33.72 Million |
| 2015 | 15.90% | 17.48% | 0.60x | 1.52x | CN¥21.28 Million |
| 2016 | 21.42% | 25.23% | 0.62x | 1.36x | CN¥52.38 Million |
| 2017 | 14.58% | 24.43% | 0.53x | 1.13x | CN¥31.51 Million |
| 2018 | 18.16% | 27.49% | 0.59x | 1.12x | CN¥65.25 Million |
| 2019 | 29.69% | 35.19% | 0.73x | 1.15x | CN¥203.45 Million |
| 2020 | 22.44% | 29.59% | 0.52x | 1.45x | CN¥122.93 Million |
| 2021 | 23.86% | 24.89% | 0.60x | 1.59x | CN¥145.53 Million |
| 2022 | 27.55% | 32.03% | 0.72x | 1.20x | CN¥256.44 Million |
| 2023 | 20.06% | 30.81% | 0.55x | 1.19x | CN¥164.70 Million |
| 2024 | 19.30% | 26.32% | 0.36x | 2.04x | CN¥166.41 Million |
| 2025 | 15.11% | 12.17% | 0.44x | 2.81x | CN¥70.98 Million |
Industry Comparison
This section compares Dalian Bio-Chem Co Ltd's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $3,574,587,449
- Average return on equity (ROE) among peers: 9.26%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Dalian Bio-Chem Co Ltd (603360) | CN¥2.05 Billion | 22.85% | 0.94x | $1.94 Billion |
| Chongqing Sanxia Paints Co Ltd (000565) | $351.19 Million | 0.65% | 0.36x | $390.84 Million |
| Hengyi Petrochemical Co Ltd (000703) | $246.42 Million | -7.64% | 1.62x | $6.57 Billion |
| Guangdong Xinhui Meida Nylon Co Ltd (000782) | $989.28 Million | 9.64% | 1.17x | $737.44 Million |
| Luxi Chemical Group Co Ltd (000830) | $17.02 Billion | 4.81% | 1.07x | $3.51 Billion |
| China Minmetals Rare Earth Co Ltd (000831) | $3.12 Billion | 24.63% | 0.08x | $9.61 Billion |
| Anhui Guofeng Plastic Industry Co Ltd (000859) | $1.08 Billion | 0.46% | 0.67x | $1.50 Billion |
| Cofco Biochemical Anhui Co Ltd (000930) | $10.20 Billion | 5.81% | 0.68x | $1.27 Billion |
| Shandong Link Science and Technology Co Ltd (001207) | $268.26 Million | 17.39% | 2.70x | $751.43 Million |
| Zhejiang Transfar Co Ltd (002010) | $104.13 Million | 34.21% | 0.82x | $1.98 Billion |
| Poly Union Chemical Holding Group Co Ltd (002037) | $2.36 Billion | 2.62% | 2.10x | $468.74 Million |
About Dalian Bio-Chem Co Ltd
Dalian BIO-CHEM Company Limited researches, develops, produces, and sells industrial fungicides in China and internationally. It offers various isothiazolinone fungicides, including CMIT/MIT, MIT, OIT, DCOIT, and BIT series products; and OEM/ODM services. The company was founded in 2003 and is headquartered in Dalian, China.